Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcaval Access for Transcatheter Aortic Valve Replacement in Patients With No Good Options for Aortic Access

NCT02280824 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT02280824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02280824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcaval Access for Transcatheter Aortic Valve Replacement in Patients With No Good Options for Aortic Access
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 1
Overall status
Completed
Start date
October 30, 2014
Completion date
December 28, 2018
Enrollment
172 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis